Tag: Patent Litigation
Patent owner’s attempt to escape a fee award by suing in a different district court goes nowhere
November 16, 2026
TRAXCELL TECHNOLOGIES, LLC v. CELLCO PARTNERSHIP Authored by: Jeremy J. Gustrowsky The Federal Circuit has shut down an unusual effort to erase an attorneys’ fee award by filing a brand-new lawsuit in a different federal district court. The court held…
Read MoreCelebrating 45 Years of Excellence: Honoring Steve Zlatos and Spiro Bereveskos
October 21, 2026
Today, we celebrate an extraordinary milestone, 45 years of dedicated service by two of our firm’s most distinguished attorneys: Stephen E. Zlatos and Spiro Bereveskos. Since joining Woodard, Emhardt, Henry, Reeves & Wagner in 1980, Steve and Spiro have each…
Read MoreFederal Circuit Raises the Bar on IPR Estoppel: Classification Searches Alone May Not Be Enough
June 18, 2026
IRONBURG INVENTIONS LTD. v. VALVE CORPORATION Authored by: Jeremy J. Gustrowsky In a second trip to the Federal Circuit involving a video game controller patent dispute, the court has provided important guidance on what it takes to prove that a…
Read MoreFederal Circuit Affirms Dismissal of Banking Patent Suit but Reverses Hefty Fee Award Against Patent Owner and Counsel
May 15, 2026
MCOM IP, LLC v. CITY NATIONAL BANK OF FLORIDA Authored by: Jeremy J. Gustrowsky The Federal Circuit recently issued a decision addressing both the dismissal of a patent infringement suit and the propriety of attorneys’ fees awarded against the patent…
Read MoreNo Do-Overs: Refiling a Complaint Won’t Restart the Clock for Mandatory ITC Stays
March 26, 2026
ASCENDIS PHARMA A/S v. BIOMARIN PHARMACEUTICAL INC. Authored by: Jeremy J. Gustrowsky When patent litigation heats up in both the International Trade Commission and federal district court simultaneously, respondents have a statutory right to pause the district court case. But…
Read MoreA Conflict of Interest Doesn’t Destroy Attorney-Client Privilege, Federal Circuit Rules
March 11, 2026
TRUSTEES OF COLUMBIA UNIVERSITY v. GEN DIGITAL INC. Authored by: Jeremy J. Gustrowsky In a case involving Columbia University’s patent dispute with Gen Digital (formerly Symantec/NortonLifeLock), the Federal Circuit reversed a civil contempt finding against the law firm Quinn Emanuel…
Read MorePatent Owner’s Shortcut Through a Complex Circuit Leads to Dead End on Infringement
February 19, 2026
GENUINE ENABLING TECHNOLOGY LLC v. SONY GROUP CORPORATION Authored by: Jeremy J. Gustrowsky When a patent claim uses “means-plus-function” language, it doesn’t describe a specific physical structure. Instead, it describes a *function*, and the patent’s specification fills in the blanks…
Read MoreNo Notice-and-Comment Required for PTO’s IPR Institution Guidelines, Federal Circuit Rules
February 13, 2026
APPLE INC. v. SQUIRES Authored by: Jeremy J. Gustrowsky When technology giants Apple, Cisco, Google, and Intel challenged the Patent and Trademark Office’s instructions for declining inter partes review (IPR) petitions, they argued the agency should have followed formal notice-and-comment…
Read MoreJury’s $10 Million Patent Damages Award Slashed to $1 After Expert Testimony Excluded
October 2, 2025
Rex Med., L.P. v. Intuitive Surgical, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed a dramatic reduction in damages in the case of Rex Medical, L.P. v. Intuitive Surgical, Inc., where a jury’s $10…
Read MoreDismissal With Prejudice Makes Defendant a “Prevailing Party” for Patent Attorney Fees
September 9, 2025
Future Link Sys., LLC v. Realtek Semiconductor Corp Authored by: Jeremy J. Gustrowsky In Future Link Systems, LLC v. Realtek Semiconductor Corp., the Federal Circuit clarified when a defendant can be considered a “prevailing party” entitled to attorney fees and…
Read MoreTax Win for Generics: Federal Circuit Says Hatch-Waxman Litigation Costs Are Deductible Business Expenses
March 21, 2025
Actavis Lab’ys FL, Inc. v. United States Authored by: Jeremy J. Gustrowsky In a major decision for the generic pharmaceutical industry, the Federal Circuit in Actavis Laboratories FL, Inc. v. United held that the legal expenses generic drug makers incur…
Read MorePatent Owners Get a Win: Federal Circuit Limits Collateral Estoppel from PTAB Decisions
February 10, 2025
Kroy IP Holdings, LLC v. Groupon, Inc Authored by: Jeremy J. Gustrowsky In a significant decision for patent owners, the Federal Circuit recently clarified when a prior Patent Trial and Appeal Board (PTAB) decision can prevent a patentee from asserting…
Read More